Neurodevelopmental outcomes in children exposed prenatally to levetiracetam

por Alsfouk, Bshra A.
Publicado 2022

Antiseizure medications use during pregnancy and congenital malformations: A retrospective study in Saudi Arabia

por Alsfouk, Bshra A., Almarzouqi, Manal Rashed, Alsfouk, Aisha A., Alageel, Saleh, Alsemari, Abdulaziz
Publicado 2021

Patterns of antiseizure medication prescription in pregnancy and maternal complications in women with epilepsy: A retrospective study in Saudi Arabia

por Alsfouk, Bshra A., Almarzouqi, Manal Rashed, Alageel, Saleh, Alsfouk, Aisha A., Alsemari, Abdulaziz
Publicado 2022

Distance Education During COVID-19 Pandemic: A College of Pharmacy Experience

por Altwaijry, Najla, Ibrahim, Alnada, Binsuwaidan, Reem, Alnajjar, Lina I, Alsfouk, Bshra A, Almutairi, Raghdah
Publicado 2021

Synthesis and Biological Evaluation of Imadazo[1,2-a]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human Coronavirus

por Alsfouk, Aisha A., Alshibl, Hanan M., Alsfouk, Bshra A., Altwaijry, Najla A., Al-Abdullah, Ebtehal S.
Publicado 2022

The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from Tagetes patula, against SARS-CoV-2

por Metwaly, Ahmed M., Elkaeed, Eslam B., Alsfouk, Bshra A., Saleh, Abdulrahman M., Mostafa, Ahmad E., Eissa, Ibrahim H.
Publicado 2022

New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches

por Alsfouk, Aisha A., Alshibl, Hanan M., Altwaijry, Najla A., Alanazi, Ashwag, AlKamaly, Omkulthom, Sultan, Ahlam, Alsfouk, Bshra A.
Publicado 2023

Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs

por Eissa, Ibrahim H., Alesawy, Mohamed S., Saleh, Abdulrahman M., Elkaeed, Eslam B., Alsfouk, Bshra A., El-Attar, Abdul-Aziz M. M., Metwaly, Ahmed M.
Publicado 2022

The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach

por Elkaeed, Eslam B., Khalifa, Mohamed M., Alsfouk, Bshra A., Alsfouk, Aisha A., El-Attar, Abdul-Aziz M. M., Eissa, Ibrahim H., Metwaly, Ahmed M.
Publicado 2022

A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study

por Eissa, Ibrahim H., Yousef, Reda G., Elkady, Hazem, Alsfouk, Aisha A., Alsfouk, Bshra A., Husein, Dalal Z., Ibrahim, Ibrahim M., Elkaeed, Eslam B., Metwaly, Ahmed M.
Publicado 2023

Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects

por Elkaeed, Eslam B., Yousef, Reda G., Elkady, Hazem, Gobaara, Ibraheem M. M., Alsfouk, Bshra A., Husein, Dalal Z., Ibrahim, Ibrahim M., Metwaly, Ahmed M., Eissa, Ibrahim H.
Publicado 2022

Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-O-(6″-O-acetyl)-Glucoside from Calligonum tetrapterum

por Suleimen, Yerlan M., Jose, Rani A., Mamytbekova, Gulnur K., Suleimen, Raigul N., Ishmuratova, Margarita Y., Dehaen, Wim, Alsfouk, Bshra A., Elkaeed, Eslam B., Eissa, Ibrahim H., Metwaly, Ahmed M.
Publicado 2022

Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease

por Suleimen, Yerlan M., Jose, Rani A., Suleimen, Raigul N., Arenz, Christoph, Ishmuratova, Margarita Y., Toppet, Suzanne, Dehaen, Wim, Alsfouk, Bshra A., Elkaeed, Eslam B., Eissa, Ibrahim H., Metwaly, Ahmed M.
Publicado 2022

Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2

por Yousef, Reda G., Eldehna, Wagdy M., Elwan, Alaa, Abdelaziz, Abdelaziz S., Mehany, Ahmed B. M., Gobaara, Ibraheem M. M., Alsfouk, Bshra A., Elkaeed, Eslam B., Metwaly, Ahmed M., Eissa, Ibrahim H.
Publicado 2022

Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway

por Taghour, Mohammed S., Elkady, Hazem, Eldehna, Wagdy M., El-Deeb, Nehal, Kenawy, Ahmed M., Elkaeed, Eslam B., Alsfouk, Bshra A., Alesawy, Mohamed S., Husein, Dalal Z., Metwaly, Ahmed M., Eissa, Ibrahim H.
Publicado 2022

Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2

por El-Metwally, Souad A., Elkady, Hazem, Hagras, Mohamed, Husein, Dalal Z., Ibrahim, Ibrahim M., Taghour, Mohammed S., El-Mahdy, Hesham A., Ismail, Ahmed, Alsfouk, Bshra A., Elkaeed, Eslam B., Metwaly, Ahmed M., Eissa, Ibrahim H.
Publicado 2023

Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies

por Elkaeed, Eslam B., Yousef, Reda G., Khalifa, Mohamed M., Ibrahim, Albaraa, Mehany, Ahmed B. M., Gobaara, Ibraheem M. M., Alsfouk, Bshra A., Eldehna, Wagdy M., Metwaly, Ahmed M., Eissa, Ibrahim H., El-Zahabi, Mohamed Ayman
Publicado 2022

Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors

por Elkady, Hazem, El-Dardir, Osama A., Elwan, Alaa, Taghour, Mohammed S., Mahdy, Hazem A., Dahab, Mohammed A., Elkaeed, Eslam B., Alsfouk, Bshra A., Ibrahim, Ibrahim M., Husein, Dalal Z., Hafez, Elsayed E., Darwish, Amira M. G., Metwaly, Ahmed M., Eissa, Ibrahim H.
Publicado 2023